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Activation of Cdc2/cyclin B kinase and entry into mitosis requires dephosphorylation of inhibitory sites on Cdc2 by Cdc25
phosphatase. In vertebrates, Cdc25C is inhibited by phosphorylation at a single site targeted by the checkpoint kinases
Chk1 and Cds1/Chk2 in response to DNA damage or replication arrest. In Xenopus early embryos, the inhibitory site on
Cdc25C (S287) is also phosphorylated by a distinct protein kinase that may determine the intrinsic timing of the cell cycle.
We show that S287-kinase activity is repressed in extracts of unfertilized Xenopus eggs arrested in M phase but is rapidly
stimulated upon release into interphase by addition of Ca2, which mimics fertilization. S287-kinase activity is not
dependent on cyclin B degradation or inactivation of Cdc2/cyclin B kinase, indicating a direct mechanism of activation by
Ca2. Indeed, inhibitor studies identify the predominant S287-kinase as Ca2/calmodulin-dependent protein kinase II
(CaMKII). CaMKII phosphorylates Cdc25C efficiently on S287 in vitro and, like Chk1, is inhibited by 7-hydroxystauro-
sporine (UCN-01) and debromohymenialdisine, compounds that abrogate G2 arrest in somatic cells. CaMKII delays
Cdc2/cyclin B activation via phosphorylation of Cdc25C at S287 in egg extracts, indicating that this pathway regulates the
timing of mitosis during the early embryonic cell cycle.
INTRODUCTION
Our understanding of how cell cycle phase transitions are
regulated has been greatly assisted by studies of the embry-
onic cell cycle and the use of cell-free systems made from
Xenopus laevis eggs. Freshly laid Xenopus eggs are kept ar-
rested in metaphase of meiosis II due to an activity known as
cytostatic factor (CSF), which maintains a high activity of
Cdc2/cyclin B protein kinase, the M phase-promoting factor
(MPF) (Masui and Markert, 1971). Fertilization of an egg by
a sperm triggers an intracellular wave of Ca2 ions (Busa
and Nuccitelli, 1985; Kubota et al., 1987) and release from
CSF arrest. This switches on the ubiquitin-conjugating com-
plex known as the anaphase-promoting complex/cyclosome
(APC/C) (King et al., 1995; Sudakin et al., 1995) that targets
proteins such as cyclin B (Glotzer et al., 1991; King et al.,
1995) for degradation by the proteasome. Consequently,
Cdc2 kinase is inactivated and exit from M phase occurs.
CSF-arrested egg extracts made by including Ca2-chelators
during preparation contain active Cdc2/cyclin B and can
assemble mitotic spindles around added chromatin (Mur-
ray, 1991). Addition of exogenous Ca2 to these extracts
(Lohka and Maller, 1985; Murray et al., 1989) inactivates CSF,
triggers cyclin B degradation, and causes exit from M phase
in vitro. The inactivation of CSF by Ca2 requires the acti-
vation of the multifunctional Ca2/calmodulin-dependent
protein kinase II (CaMKII) (Lorca et al., 1993; Morin et al.,
1994), which presumably phosphorylates proteins involved
in the regulation of the APC/C (Reimann and Jackson,
2002).
After fertilization, there is a prolonged interphase of 75–90
min during which cyclin B is gradually synthesized before
entry into the first mitosis (Murray et al., 1989). The mecha-
nism controlling entry into mitosis can be studied in inter-
phase egg extracts in which MPF activation is initiated by
the addition of cyclin B in the form of either mRNA or
purified protein (Minshull et al., 1989; Murray and Kirsch-
ner, 1989; Solomon et al., 1990). In addition to a requirement
for a threshold level of cyclin B, the timing of MPF activation
is determined by the phosphorylation state of the complex.
Phosphorylation of T161 on Cdc2 is essential for activity, but
the kinase is kept inactive during interphase by dominant
inhibitory phosphorylation at T14 and Y15, catalyzed by
Myt1 and Wee1 kinases. The final activation step is the
removal of these inhibitory phosphates by the dual-specific-
ity protein phosphatase Cdc25 (Dunphy, 1994).
Cdc25 is itself highly regulated by reversible phosphory-
lation. In mitosis, Cdc25C is activated by phosphorylation at
multiple sites (Izumi et al., 1992; Kumagai and Dunphy,
1992) catalyzed by the polo-like kinase Plx1 (Kumagai and
Dunphy, 1996) and by Cdc2/cyclin B itself (Hoffmann et al.,
1993; Izumi and Maller, 1993), the latter creating a feedback
mechanism that promotes the rapid activation of Cdc2/
cyclin B during entry into mitosis. During interphase and in
response to checkpoint stimuli, Cdc25C is phosphorylated
on an inhibitory serine residue (S287 in Xenopus, S216 in
human), which promotes the binding of a 14-3-3 protein
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(Peng et al., 1997; Kumagai et al., 1998b). Mutation of this
serine to a nonphosphorylatable alanine shows that this
phosphorylation site is critical for determining the length of
interphase and for restraining mitotic initiation in response
to checkpoint stimuli in both Xenopus egg extracts (Kumagai
et al., 1998b) and mammalian cells (Peng et al., 1997). En-
zymes that catalyze the phosphorylation of S287/S216 in-
clude the checkpoint kinases Chk1 and Cds1/Chk2, which
in vertebrates are activated in response to replicating DNA
and double-stranded DNA breaks, respectively (Sanchez et
al., 1997; Kumagai et al., 1998a; Guo and Dunphy, 2000;
Michael et al., 2000). Phosphorylation by Chk1 or Cds1/
Chk2 down-regulates Cdc25C by inhibiting its catalytic ac-
tivity (Blasina et al., 1999; Furnari et al., 1999). In addition,
14-3-3 protein binding to the phosphorylated site has the
dual roles of preventing the nuclear translocation of Cdc25C
(Dalal et al., 1999; Kumagai and Dunphy, 1999; Lopez-Gi-
rona et al., 1999) and inhibiting the dephosphorylation of the
site by a type-2A protein phosphatase (Hutchins et al., 2002).
DNA damage checkpoints, however, do not normally op-
erate in the early embryonic cell cycles in Xenopus without
high concentrations of exogenous DNA (Dasso and New-
port, 1990). Furthermore, removal of both Chk1 and Cds1/
Chk2 from Xenopus egg extracts has been reported to reduce
S287-kinase activity by only 30% (Guo and Dunphy, 2000),
indicating the existence of additional protein kinase(s) that
keep S287 phosphorylated during interphase and thereby
determine the normal timing of entry into mitosis. In this
article, we show that S287 phosphorylation is repressed in
M-phase (CSF-arrested) Xenopus egg extracts and is acti-
vated upon release into interphase by the addition of Ca2.
Kinase activity toward S287 of Cdc25C in interphase extracts
is Ca2 dependent and attributable to CaMKII. Phosphory-
lation of S287 is catalyzed efficiently by purified CaMKII and
is inhibited by compounds that also inhibit Chk1 and over-
come G2 arrest. Activation of CaMKII by Ca2 delays Cdc2
activation by inhibiting Cdc25C via phosphorylation of
S287. Together, these data identify a novel pathway by
which the timing of mitosis is regulated by CaMKII via
inhibitory phosphorylation of Cdc25C.
MATERIALS AND METHODS
Proteins and General Reagents
All chemicals were from Sigma-Aldrich (St. Louis, MO) unless specified
otherwise. Full-length Xenopus Cdc25C was polymerase chain reaction-am-
plified from the cDNA clone (Izumi et al., 1992) with the addition of an
N-terminal His6-tag and cloned into the pFastBac1 vector (Invitrogen, Carls-
bad, CA). His6-Cdc25C protein was expressed in baculovirus-infected insect
cells and purified by metal-affinity chromatography. Glutathione S-trans-
ferase (GST)-tagged Cdc25C(271-316) protein and variants were expressed in
Escherichia coli (Hutchins et al., 2002). GST-hChk1 was produced by baculo-
virus expression as described previously (Hutchins et al., 2000). Recombinant
CaMKII enzyme (New England Biolabs, Beverly, MA) was activated by prior
incubation with 2 mM CaCl2, 1.2 M calmodulin and 100 M ATP in 50 mM
Tris-HCl, pH 7.5, 10 mM MgCl2, 2 mM dithiothreitol at 30°C for 10 min.
CaMKII(281-309) peptide, CaMK IINtide, and debromohymenialdisine (DBH)
were from Calbiochem (San Diego, CA). 1,2-bis(o-Amino-5-bromophe-
noxy)ethane-N,N,N,N-tetraacetic acid (Br2BAPTA) was from Molecular
Probes (Eugene, OR). Tautomycin was from BIOMOL Research Laboratories
(Plymouth Meeting, PA). 7-Hydroxystaurosporine (UCN-01) was a gift from
Dr. R.J. Schultz (Drug Synthesis and Chemistry Branch, National Cancer
Institute, Bethesda, MD); a 10 mM stock solution was prepared in dimethyl
sulfoxide. Poly(dT)70 and poly(dA)70 oligonucleotides synthesized and puri-
fied by MWG Biotech were annealed as described previously (Guo and
Dunphy, 2000).
Peptide Synthesis and Anti-phospho-S287
Antibody Production
The SPS peptide (RLYRSPSMPEKLDRK) derived from residues 281–294 of
Xenopus Cdc25C, the variant peptides APS and SPA, the phosphopeptides
S*PS and SPS* (where S* is pSer), and the destruction box (D-box) peptide
(RRTALGDVTNKVSE) were synthesized and purified by Dr. G. Bloomberg
(University of Bristol, Bristol, United Kingdom). The AMARA peptide (AMA-
RAASAAALARRR) was synthesized by Chiron (Victoria, Australia). To gen-
erate the -pS287 antibody, the SPS* peptide was coupled to bovine serum
albumin and used to raise a rabbit polyclonal antiserum by a commercial
facility (Moravian Biotechnology, Brno, Czech Republic). The antiserum was
then affinity purified on a column containing immobilized SPS* phosphopep-
tide.
Xenopus Egg Extracts
Interphase extracts of X. laevis eggs prepared as 10,000  g supernatants by
crushing eggs in the absence of calcium chelators (Murray, 1991) were sup-
plemented with 5% (vol/vol) glycerol, snap-frozen in 100-l aliquots, and
stored in liquid nitrogen. CSF-arrested egg extracts were prepared with the
addition of EGTA to buffers (Murray, 1991) and were used without freezing.
In experiments where mitosis was induced in interphase egg extract, 2 M
Arbacia punctulata cyclin B90 protein (Glotzer et al., 1991) was added to egg
extract containing 10 g/ml cycloheximide in a total volume of 10 l. Samples
of extract (1 l) were then taken at various times for measurement of Cdc2/
cyclin B kinase activity by using histone H1 as substrate (Clarke, 1995). Where
kinase activity was measured in CSF extract, samples (2 l) were frozen in
liquid nitrogen for assay later.
Western Blotting
Proteins were separated on 12% polyacrylamide gels and transferred to
nitrocellulose. Blots were blocked with phosphate-buffered saline plus 0.1%
(vol/vol) Tween 20 (PBST) containing 5% (wt/vol) milk powder (PBSTM) for
30 min at room temperature and probed for 60 min with primary antibodies
-pS287 (rabbit) or -PSTAIR (mouse monoclonal; Sigma-Aldrich), diluted
1:1000 in PBSTM. After washing extensively in PBST, the blots were probed
by horseradish peroxidase-coupled anti-rabbit or anti-mouse IgG (Amersham
Biosciences, Piscataway, NJ) (1/1000 dilution in PBSTM, 60 min), extensively
washed with PBST, and developed by chemiluminescence.
Phosphorylation of the S287 Residue of Cdc25C in
Xenopus Egg Extracts
GST-Cdc25C(271-316) protein (100 g/ml) was added to interphase Xenopus
egg extract diluted 1:10 in buffer AM (20 mM HEPES-KOH, pH 7.5, 150 mM
NaCl, 2 mM dithiothreitol, 10 mM MgCl2) plus 1 mM ATP, 1 mg/ml bovine
serum albumin, 1 mM benzamidine, and 0.1 mM phenylmethylsulfonyl flu-
oride. Samples of extract (1 l) were taken at the desired time, added to 15 l
of 2 SDS-PAGE sample buffer, and analyzed by Western blotting with the
-pS287 antibody.
Protein Kinase Assays
GST-Cdc25C(271-316) protein was phosphorylated in a reaction containing 1
pmol of kinase, in buffer AM plus 100 M [-32P]ATP (approx. 7.4 kBq/
nmol), at room temperature for 15 min. Full-length His6-Cdc25C protein was
first dephosphorylated by protein phosphatase 2A (PP2A; Upstate Biotech-
nology, Lake Placid, NY) for 60 min at 30°C, and then 1 M okadaic acid
(Calbiochem) was added to inhibit the phosphatase before incubation with
CaMKII for a further 60 min. Phosphorylated proteins were separated on
SDS-12% PAGE gels and analyzed by autoradiography or Western blotting.
Peptides (100 M) were phosphorylated under the same conditions, except
where specified, and analyzed as described previously (Hutchins et al., 2000).
Peptide kinase assays were carried out in duplicate. In experiments examin-
ing the effect of UCN-01 and DBH, reactions also contained 10% (vol/vol)
dimethyl sulfoxide.
In Vitro Expression of Xenopus Cdc25C, Cds1, Chk1KD,
and Cyclin B1
Full-length Xenopus Cdc25C cDNA was subcloned into the pcDNA3.1 vector
(Invitrogen). The S287A (SPA) mutant of this clone was generated using the
QuikChange site-directed mutagenesis kit from Stratagene. Full-length Xeno-
pus Cds1 (Xcds1) cDNA was amplified from a Xenopus oocyte cDNA library
(Nicola´s et al., 1997) by PCR, using the primers 5-CATATG ATGATG
TCTCGT GATACT AAAAC-3 and 5-CTCGAG TTATCT TTTTGC TCTCTT
TTCG-3, and cloned into the pGEM-T Easy vector (Promega). After sequenc-
ing, the Xcds1 cDNA was subcloned into pcDNA3.1. Xenopus cyclin B1 cDNA
was also subcloned into pcDNA3.1. A cDNA clone encoding amino acids
260–474 (i.e., the C-terminal regulatory domain) of Xenopus Chk1
(Xchk1KD) in pET28a was a gift from Dr. W. M. Michael (Harvard Univer-
sity, USA). These plasmids were used to express 35S-labeled proteins using
the TnT reticulocyte lysate in vitro transcription/translation system (Pro-
mega) in the presence of l-[35S]methionine (Amersham Biosciences) accord-
ing to the manufacturer’s protocol.
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RESULTS
Specific Antibody Recognition of S287 Phosphorylation
of Cdc25C
To investigate the phosphorylation status of the S287 residue
of Xenopus Cdc25C, we raised a polyclonal antiserum
against a phosphopeptide derived from this region contain-
ing phosphoserine (pSer) at position 287 (Figure 1A) and
affinity purified the antibody (-pS287) on a column contain-
ing immobilized phosphopeptide. The purified antibody
recognized peptides derived from Xenopus Cdc25C in which
the residue corresponding to serine-287 was phosphory-
lated, but did not recognize the unphosphorylated peptide
or a peptide in which S285 was phosphorylated (Figure 1B).
-pS287 also recognized pS287 within a GST-tagged frag-
ment of Cdc25C, corresponding to residues 271–316 of the
N-terminal regulatory domain [GST-Cdc25C(271-316), SPS
protein], which had been phosphorylated on S287 by Chk1
(Figure 1C). Mutation of S287 to nonphosphorylatable ala-
nine (SPA protein) prevented recognition by the antibody,
whereas a protein in which S285 is mutated to alanine (APS
protein) that is equally well phosphorylated at S287 by Chk1
is recognized. The antibody is therefore specific for the
phosphorylated S287 site in Xenopus Cdc25C.
Cell Cycle Changes in S287-Kinase Activity in Xenopus
Egg Extracts
To investigate changes in S287-phosphorylation status be-
tween M phase and interphase, a CSF-arrested egg extract
was incubated with addition of either buffer (which main-
tained CSF arrest) or 0.8 mM Ca2, which induced release
into interphase assessed by the decline of Cdc2/cyclin B
protein kinase activity (Figure 2). Extracts released from CSF
arrest synthesized cyclin B, reactivated Cdc2/cyclin B ki-
nase, and entered mitosis after a 105- to 120-min incubation.
Samples were taken at different times for analysis by West-
ern blotting with -pS287. Although the CSF-arrested ex-
tract displayed a very low level of S287-phosphorylation, the
extent of S287-phosphorylation of endogenous Cdc25C after
Ca2 addition was greatly increased until 75–90 min, when
phosphorylation declined before reactivation of Cdc2/cyclin
B and entry into mitosis at 105–120 min (Figure 2B, top). This
analysis was complicated, however, by the shifting of en-
dogenous Cdc25C to a number of more rapidly migrating
forms, consistent with dephosphorylation of mitotic sites
(Peng et al., 1997; Kumagai et al., 1998b). To analyze S287
kinase activity more readily, the extracts were supple-
Figure 1. Specific recognition of the phospho-S287 residue within
Xenopus Cdc25C. (A) Location of the S287 residue within full-length
Cdc25C, the 271-316 fragment, and peptide. (B) Dot blot of 1 nmol
of each peptide (or 1 l of buffer), showing specific recognition of
phospho-S287 by the -pS287 antibody. (C) Western blot of GST-
Cdc25C(271-316) SPS, APS, and SPA proteins incubated with Chk1
with or without Mg.ATP, as indicated, showing specific recognition
of phospho-S287 by -pS287.
Figure 2. Phosphorylation status of the Cdc25C(S287) residue
changes during the cell cycle. A CSF-arrested (M-phase) egg extract
containing GST-Cdc25C(271-316) SPS protein was induced to cycle
by the addition of 0.8 mM CaCl2. Top, Cdc2 (histone H1 kinase)
activity profile; bottom, -pS287 Western blot showing phosphory-
lation status of S287 in endogenous Cdc25C (end.) and exogenous
GST-Cdc25C(271-316) (exo.).
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mented with GST-Cdc25C(271-316) (Figure 2, bottom),
which was strongly phosphorylated at S287 after Ca2-in-
duced CSF release. Phosphorylation of S287 declined after
75 min, reaching a nadir at 120 min, corresponding to the
peak of Cdc2/cyclin B activity, and then was rephosphory-
lated as Cdc2/cyclin B activity dropped in the second inter-
phase. This oscillation in S287 phosphorylation suggests that
S287-kinase activity is stimulated upon Ca2-induced re-
lease from M-phase exit, is inhibited before the first mitosis
and is then reactivated during the second interphase.
S287 Phosphorylation during Mitotic Exit Is Independent
of Cyclin B Degradation and Cdc2 Inactivation
The observation that S287 was phosphorylated upon Ca2-
induced CSF release led us to address whether activation of
S287-kinase is a consequence of the degradation of cyclin B
and loss of Cdc2/cyclin B activity. GST-Cdc25C(271-316)
protein was first incubated in a CSF-arrested egg extract
(supplemented with 35S-labeled Xenopus cyclin B1) for 10
min and then 0.8 mM Ca2 was added to induce M-phase
exit, and samples of extract were taken at different times to
analyze Cdc2/cyclin B activity, S287 phosphorylation status,
and cyclin B1 stability (Figure 3). CSF release caused a
steady reduction in histone H1 kinase activity, and there was
a corresponding degradation of 35S-cyclin B1 that became
noticeable 10 min after addition of Ca2 (20-min incubation
in total). However, S287 phosphorylation occurred much
more rapidly after Ca2 addition, reaching a level within 1
min that persisted for at least the proceeding 40 min.
The activity of the APC/C can be inhibited in a compet-
itive manner by a small protein or peptide containing a
D-box motif (Holloway et al., 1993; Peter et al., 2001;
Reimann and Jackson, 2002). To determine whether the deg-
radation of cyclin B and inactivation of Cdc2 kinase is re-
quired for the phosphorylation of S287, we added a D-box
peptide to a CSF extract before the addition of CaCl2. When
this peptide was present in the extract, the inactivation of
Cdc2 and degradation of cyclin B1 induced by Ca2 were
blocked (Holloway et al., 1993), but S287 still became phos-
phorylated (Figure 4). Therefore, inactivation of Cdc2/cyclin
B is not required for S287 phosphorylation to occur during
mitotic exit, suggesting that activation of S287 phosphoryla-
tion is induced independently by Ca2 addition.
S287 Phosphorylation in Interphase Egg Extract
Requires CaMKII
One explanation for the rapid phosphorylation of S287 in an
egg extract after Ca2 addition could be that the protein
kinase that catalyzes the phosphorylation of S287 is directly
activated by Ca2. To test this possibility, we analyzed the
effects of manipulating Ca2 levels on kinase activity toward
S287 by using GST-Cdc25C(271-316) as a substrate. In a
dilute egg extract prepared by crushing eggs in the absence
of exogenous Ca2 or Ca2 chelators, the basal level of S287
phosphorylation was almost completely inhibited by the
Ca2-chelating agent Br2BAPTA, demonstrating that the
basal kinase activity is dependent on endogenous Ca2 (Fig-
ure 5A). The extent of this activity was somewhat different
between extracts, which probably reflects variability in the
amount of free Ca2 released from intracellular stores dur-
ing extract preparation. S287 kinase activity was strongly
stimulated by addition of Ca2. By assessing S287 phosphor-
ylation in an extract with low levels of basal S287 kinase
activity, we established that the S287-kinase is very sensitive
to Ca2, its activity being stimulated in the nanomolar to
micromolar range (Figure 5B).
A prime candidate for the Ca2-stimulated S287-kinase in
the egg extract is the multifunctional Ca2/calmodulin-de-
pendent protein kinase II (CaMKII), which is present in
Xenopus oocytes, eggs, and embryonic tissues (Schulman
and Greengard, 1978; Stevens et al., 2001; Matsumoto and
Maller, 2002). CaMKII is kept inactive in the absence of
Figure 3. Effect of CaCl2 on CSF-release and on S287 phosphory-
lation. A CSF-arrested egg extract, supplemented with GST-
Cdc25C(271-316) SPS protein and 35S-cyclin B1 was treated with
either 0.8 mM CaCl2 or buffer, as indicated, immediately after the
10-min time point (indicated by arrow). Top, Cdc2 (histone H1
kinase) activity time course; middle, stability of 35S-cyclin B1 ana-
lyzed by SDS-PAGE and autoradiography; and bottom, Cdc25C
(S287) phosphorylation status analyzed by Western blotting.
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Ca2/calmodulin by an autoinhibitory domain, which in-
teracts with the ATP-binding and protein substrate-binding
sites, blocking the active site of the enzyme (Hudmon and
Schulman, 2002). Peptides derived from the autoinhibitory
domain of CaMKII specifically inhibit the kinase (Colbran et
al., 1988; Payne et al., 1988), allowing the role of this enzyme
to be examined in vivo and in cell extracts (Lorca et al., 1993;
Matsumoto and Maller, 2002). As shown in Figure 5C, ad-
dition of one such peptide, CaMKII(281-309), completely
blocked Ca2-stimulated S287-kinase activity in diluted egg
extract, demonstrating that this kinase activity is dependent
on CaMKII. The majority of S287 kinase activity in a con-
centrated interphase extract (prepared without exogenous
Ca2) was also strongly inhibited by both Br2BAPTA (Figure
5D) and the CaMKII(281–309) peptide (Figure 5E). An un-
related peptide derived from a CaMKII inhibitor protein
(CaMK IIN) that specifically inhibits CaMKII and not closely
related Ca2-stimulated kinases such as CaMKI and
CaMKIV (Chang et al., 1998) also completely inhibited S287
kinase activity in interphase egg extracts (Figure 5E), show-
ing that CaMKII is required for the phosphorylation of S287
of Cdc25C during interphase.
CaMKII Phosphorylates Cdc25C on S287
Peptide substitution and degenerate peptide library studies
have established the minimal sequence motif for phosphor-
ylation by CaMKII as being -X-R-(NB)-X-S/T*-, where 
is a hydrophobic residue, NB is a nonbasic residue, and X is
Figure 4. CaCl2 induces Cdc25C(S287) phosphorylation indepen-
dently of cyclin B degradation. A CSF-arrested egg extract, supple-
mented with GST-Cdc25C(271-316) SPS protein and 35S-cyclin B1,
was treated with either 2 mM D-box peptide (DBP) or buffer at zero
time, and either 0.8 mM CaCl2 or buffer at 10 min, as indicated. Top,
Cdc2 (histone H1 kinase) activity time course. Bottom,
Cdc25C(S287) phosphorylation status analyzed by Western blotting,
and 35S-cyclin B1 stability analyzed by SDS-PAGE and autoradiog-
raphy.
Figure 5. Characterization of S287-kinase activity in dilute (1:10)
(A–C) and concentrated (D and E) interphase egg extract. GST-
Cdc25C(271-316) SPS protein was added to the extracts with the
following additions: 1 mM Br2BAPTA or 0.8 mM CaCl2 (A), the
indicated concentration of added CaCl2 (B), 0.8 mM CaCl2 or 0.4
mM CaMKII(281-309) peptide (C), 1 mM Br2BAPTA (D), and 0.4
mM CaMKII(281-309) peptide or CaMK IINtide (E). Samples were
removed after 1, 2, and 5 min (A, C, D, and E) or 5 min (B), and S287
phosphorylation was analyzed by Western blotting with -pS287
antibody.
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any amino acid (Songyang et al., 1996; White et al., 1998). The
amino acid sequence surrounding the S287 residue of Xeno-
pus Cdc25C (. . . RSRLYRSPS287MPEK. . . ) shows a perfect
match with the motif for CaMKII as well as that for Chk1
(Hutchins et al., 2000), suggesting that CaMKII targets this
residue directly like Chk1.
To test whether S287 is phosphorylated by CaMKII, we
produced full-length recombinant Xenopus Cdc25C in bacu-
lovirus-infected insect cells. The purified protein was al-
ready fully phosphorylated on S287, but after dephosphor-
ylation by protein phosphatase-2A, recombinant CaMKII
catalyzed the phosphorylation of that site (Figure 6A).
CaMKII, like Chk1, also phosphorylated GST-Cdc25C(271-
316) determined by incorporation of 32P-phosphate (Figure
6B). Both SPS and APS variants were phosphorylated
equally well by CaMKII, whereas Chk1 preferred the APS
protein in which serine 285 is mutated. The SPA protein was
not phosphorylated by either kinase, showing their specific-
ity for serine 287.
To compare the rates of S287 phosphorylation by CaMKII
and Chk1, we used an in vitro peptide kinase assay (Glass et
al., 1978; Hutchins et al., 2000). Identical amounts of purified
CaMKII and Chk1 catalyzed phosphorylation of the Cdc25C
SPS peptide (RLYRSPSMPEKLDRK) at very similar rates
(Figure 6C). The APS peptide (RLYRAPSMPEKLDRK) was
also phosphorylated well by both kinases. However, the
AMARA peptide (AMARAASAAALARRR) that is a mini-
mal substrate for several members of this family of protein
kinases (Dale et al., 1995) was a very poor substrate for
CaMKII, although it was a good substrate for Chk1, indicat-
ing that there are some differences between the substrate
specificities of these two kinases (Figure 6C). The SPS pep-
tide kinase activity of CaMKII was absolutely dependent on
the presence of Ca2/calmodulin and was completely
blocked by the CaMKII(281-309) peptide, whereas Chk1 was
not stimulated by Ca2/calmodulin and was only slightly
inhibited by this peptide (our unpublished data). Together,
these data show that CaMKII can directly phosphorylate the
S287 residue of Cdc25C in vitro and is very likely to account
for the Ca2-stimulated S287 kinase activity in egg extracts.
Inhibitor Sensitivity of CaMKII and Chk1
Chk1 is inhibited by UCN-01 and DBH, compounds that
abrogate G2 checkpoints in mammalian cells (Wang et al.,
1996; Busby et al., 2000; Graves et al., 2000; Curman et al.,
2001) and overcome DNA damage-induced inhibition of
Cdc2/cyclin B activation in Xenopus egg extracts (our un-
published data). UCN-01 strongly inhibited CaMKII in pep-
tide kinase assays, being effective at an even lower IC50
value (2.9 nM) than with Chk1 (7.7 nM) (Figure 7A). CaMKII
was also inhibited by DBH with an IC50 value of 16.3 M,
compared with 8.6 M for Chk1 (Figure 7B). In egg extracts,
Ca2-stimulated S287 kinase activity was partially inhibited
by UCN-01 at 1 M and blocked by 10 M, whereas DBH
inhibited at 1 mM (Figure 7C). Thus, although these com-
pounds do not distinguish between Chk1 and CaMKII in
egg extracts, the results are consistent with the predominant
Ca2-activated S287 kinase activity being CaMKII. It is likely
that higher concentrations are required for inhibition in
extracts than with purified enzymes due to binding to other
targets and a higher, competing ATP concentration (1 mM).
Ca2-induced Inhibition of Cdc2/Cyclin B Activation via
Targeting of S287 on Cdc25C by CaMKII
To determine whether CaMKII plays a role in the timing of
Cdc2/cyclin B kinase activation and entry into mitosis, we
Figure 6. Phosphorylation of Cdc25C by CaMKII and Chk1 in vitro. (A)
Phosphorylation of recombinant full-length His6-Cdc25C (100 ng) by
CaMKII after treatment with protein phosphatase 2A (PP2A) and then
okadaic acid, as indicated. Top, -pS287 Western blot; bottom, 32P auto-
radiograph. (B) Phosphorylation of GST-Cdc25C(271-316) SPS, APS, or
SPA protein (1 g) by Chk1 or CaMKII (1 pmol). Phosphorylation of
GST-Cdc25C(271-316) SPS, APS, or SPA protein (1 g) by Chk1 or
CaMKII (1 pmol). Top, 32P autoradiograph; bottom, Coomassie-stained
SDS-PAGE gel. (C) Time course of phosphorylation of synthetic peptides
(as described in the text) by Chk1 (top) or CaMKII (bottom).
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used interphase Xenopus egg extracts containing cyclohexi-
mide, which prevents synthesis of endogenous cyclins. Cdc2
kinase activity and migration on SDS-PAGE were monitored
after addition of recombinant cyclin B (cyclin B90) that
lacks the D-box sequence by which it is targeted for degra-
dation (Solomon et al., 1990; Glotzer et al., 1991). Consistent
with previous results (Solomon et al., 1990; Clarke et al.,
1992), cyclin B90 caused the transient upshift of Cdc2 on
SDS-PAGE after 15-min incubation due to phosphorylation
at T14 and Y15 (Figure 8). After 30-min incubation, Cdc2
became activated, and there was a corresponding increase in
mobility on SDS-PAGE due to dephosphorylation of T14
and Y15 by Cdc25C. Phosphorylation at T161 caused the
active form of Cdc2 to migrate slightly faster than the non-
phosphoryated form. As expected, addition of vanadate
ions, which inhibit Cdc25C, prevented activation of Cdc2/
cyclin B90 and caused accumulation of the upshifted, T14/
Y15-phosphorylated form of Cdc2 when cyclin B90 was
present.
When added simultaneously with the cyclin, 0.8 mM Ca2
blocked Cdc2/cyclin B90 activation and caused accumula-
tion of the slower migrating form of Cdc2 phosphorylated
on T14/Y15. The block caused by Ca2 (but not vanadate)
was overcome by addition of the CaMKII(281-309) peptide
with corresponding dephosphorylation of T14/Y15 (Figure
8). Similarly, inhibition of Cdc2/cyclin B90 activation by
Ca2 was relieved by UCN-01 (our unpublished data). Thus,
Ca2 acts via CaMKII to inhibit the dephosphorylation of
T14/Y15 on Cdc2 by Cdc25C, thereby blocking Cdc2/cyclin
B90 activation. The inhibitory effect of Ca2 was partially
reversed by addition of full-length Cdc25C in which serine
287 was mutated to alanine (SPA), but not wild-type (SPS)
Cdc25C (Figure 9). CaMKII therefore inhibits Cdc2/cyclin B
activation through the inhibition of Cdc25C by phosphory-
lation at S287.
Given that the protein kinases Chk1 and Cds1/Chk2 have
already been identified as targeting S287 of Cdc25C, the
formal possibility remained that CaMKII activated by Ca2
increased S287 phosphorylation in extracts by acting
through these kinases. Both Chk1 (Walworth and Bernards,
1996; Kumagai and Dunphy, 2000; Michael et al., 2000) and
Chk2/Cds1 (Matsuoka et al., 1998; Guo and Dunphy, 2000)
undergo a characteristic phosphorylation and retardation in
mobility on SDS-PAGE, in response to the activation of
DNA structure checkpoints. As shown previously (Guo and
Dunphy, 2000; Kumagai and Dunphy, 2000), oligonucleo-
tides that generate a checkpoint signal in Xenopus egg ex-
tracts caused a retardation in the mobility of Chk1 and Cds1
(Figure 10). In contrast, 0.8 mM Ca2, which also produced
phosphorylation of Cdc25C on S287 (Figure 5) and delayed
Cdc2/cyclin B activation (Figure 8), failed to induce phos-
phorylation of Chk1 or Cds1. Thus, CaMKII does not act via
inhibition of Chk1 or Cds1, indicating that these kinases
function in distinct pathways that converge on the phos-
phorylation and inhibition of Cdc25C.
DISCUSSION
The timing of mitosis is controlled by the abundance of
cyclin B and changes in the phosphorylation status of the
Cdc2/cyclin B complex, determined by the activities of pro-
tein kinases and phosphatases toward the Cdc2 and cyclin B
subunits. These posttranslational mechanisms permit con-
trol by positive and negative feedback pathways that are
regulated by extracellular hormonal signals, for instance
during oocyte maturation; by checkpoints activated by DNA
Figure 7. Inhibition of CaMKII, Chk1, and S287 kinase activity in
egg extracts by UCN-01 and DBH. Sensitivity of purified Chk1 and
CaMKII, assayed using a Cdc25C-peptide substrate, to UCN-01 (A)
and DBH (B). (C) Inhibition of S287-kinase activity toward GST-
Cdc25C SPS-protein in dilute (1:10) interphase egg extract to
UCN-01 and DBH. Samples were removed after 5-min incubation,
and S287 phosphorylation was analyzed by Western blotting with
-pS287 antibody.
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damage, replication arrest, and probably other stress signals;
and by intrinsic timing mechanisms that determine the pe-
riod of cell cycle oscillations in an early embryo such as that
of Xenopus (Murray, 1992). A critical event in the activation
Figure 8. Inhibition of Cdc2/cyclin B activation by Ca2. Top, time
course of Cdc2 (histone H1 kinase) activation initiated by addition of 2
M cyclin B90 (90) to interphase egg extract, with further additions
of 0.8 mM CaCl2 (Ca), 0.4 mM CaMKII(281-309) peptide (pep), and 1
mM Na vanadate (van), as indicated. Bottom, analysis of the phos-
phorylation status of Cdc2 in samples of extract taken at the indicated
time points, analyzed by SDS-PAGE and Western blotting with a
-PSTAIR antibody. The major band is p34cdc2, which shifts up when
phosphorylated on the inhibitory sites T14 and Y15, and shifts down
when it is phosphorylated on T161 and activated. The lower weak
reactive band is p33cdk2, which does not form a complex with cyclin
B90 (Solomon et al., 1990; Clarke et al., 1992).
Figure 9. Rescue of the inhibition of the Ca2-induced inhibition
of Cdc2/cyclin B activation by a Cdc25C mutant lacking the inhib-
itory phosphorylation site. (A) Time course of Cdc2 (histone H1
kinase) activation initiated by addition of 2 M cyclin B90 (90) to
interphase egg extract in the presence of 0.8 mM CaCl2 with addi-
tion of in vitro translated Cdc25C S287A (SPA) or wild-type Cdc25C
(SPS). Control incubations contained reticulocyte lysate (1/10th total
volume) lacking recombinant Cdc25C.
Figure 10. Activation of Chk1 and Cds1/Chk2 in egg extract by DNA
oligonucleotides, but not by CaCl2. Autoradiographs show the migra-
tion on SDS-PAGE of 35S-labeled, in vitro-translated Xcds1 or
Xchk1KD incubated for the indicated time in interphase egg extract
containing 50 ng/l poly(dA)70:poly(dT)70 DNA oligonucleotide du-
plex (DNA oligo) or 0.8 mM CaCl2. Incubations with Xchk1KD also
contained 3 M tautomycin (Kumagai and Dunphy, 2000).
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of Cdc2/cyclin B is the dephosphorylation of inhibitory sites
on Cdc2 by Cdc25 phosphatase. Cdc25C is activated in
mitosis by phosphorylation at multiple sites, but phosphor-
ylation at a single site (S287 in Xenopus Cdc25C) restrains its
activation during interphase. This study describes changes
in the phosphorylation status of S287 of Cdc25C in Xenopus
egg extracts and identifies the major kinase acting on this
site in interphase extracts as CaMKII. Phosphorylation and
inhibition of Cdc25C by CaMKII inhibits Cdc2/cyclin B
activation during the first interphase and may play a role in
the intrinsic timing of the cell cycle in the early embryo.
Dual Control of Cdc25C Inhibition and Cyclin B
Degradation by CaMKII
Release of Xenopus eggs from CSF arrest in meiosis II into
interphase upon fertilization involves an increase in intra-
cellular Ca2 concentration ([Ca2]i) and activation of
CaMKII. In CSF-arrested egg extract prepared in the pres-
ence of the Ca2 chelator EGTA, cyclin B is stable, but
addition of Ca2 triggers CaMKII activation (Matsumoto
and Maller, 2002), activation of APC/C (King et al., 1995;
Sudakin et al., 1995), and cyclin B polyubiquitination and
degradation (Glotzer et al., 1991), resulting in inactivation of
Cdc2 kinase (MPF) (Lorca et al., 1993). Although the mech-
anism by which CaMKII activates the APC/C is not clear, it
may involve the inactivation of Emi1, which suppresses the
APC/C activator Cdc20 during CSF arrest (Reimann and
Jackson, 2002). In these experiments, a high concentration of
CaCl2 (typically 0.4–0.8 mM) was added, but the Ca2-
buffering capacity of concentrated extracts is such that the
free [Ca2] is only in the micromolar range. This free [Ca2]
is sufficient to activate CaMKII, but not general proteases
activated by Ca2 (Lorca et al., 1991, 1993; Lindsay et al.,
1995; Matsumoto and Maller, 2002), and is comparable to
that generated in vivo after fertilization of the egg (Busa and
Nuccitelli, 1985; Kubota et al., 1987; Lindsay et al., 1995).
We have found that activation of CaMKII under these
conditions also causes phosphorylation of Cdc25C at the
inhibitory site, S287. Indeed, CaMKII is the predominant
kinase acting on this site in interphase egg extracts. Together
with dephosphorylation of the activating phosphorylation
sites on Cdc25C (Kumagai and Dunphy, 1992) and activa-
tion of the opposing Myt1 and Wee1 kinases (which target
the inhibitory T14 and Y15 residues on Cdc2) (Mueller et al.,
1995a,b) on exit from M phase, this mechanism would pre-
vent premature reactivation of Cdc2/cyclin B kinase as cy-
clin B is synthesized and associates with Cdc2 during the
subsequent interphase. Thus, both cyclin B degradation and
inhibition of Cdc25C are coupled by activation of CaMKII
upon release from CSF arrest by Ca2 (Figure 11A).
Inhibition of Cdc2/cyclin B Activation by CaMKII-
mediated S287 Phosphorylation
The phosphorylation of S287 of Cdc25C upon release into
interphase is maintained in cycling egg extracts until just
before Cdc2/cyclin B activation and entry into mitosis.
Phosphorylation of S287 is very low during mitosis and is
reactivated in the subsequent interphase, albeit less strongly
than after the initial addition of Ca2. This oscillation in
phosphorylation status of S287 in extracts closely matches
the situation in vivo in fertilized Xenopus embryos (Duck-
worth et al., 2002). Phosphorylation of S287 in extracts per-
sists for 75–90 min after release from CSF arrest, even after
[Ca2] is likely to have dropped to basal levels due to uptake
into organelles and CaMKII activity has declined (Matsumo-
to and Maller, 2002). It is probable that the stability of S287
Figure 11. Models for the role of CaMKII in the control of Cdc25C.
(A) Dual regulation of APC/C activation and Cdc25C inhibition in
Xenopus eggs upon release from arrest in M phase. Fertilization
induces an increase in [Ca2]i and activates CaMKII. This causes the
activation of the APC/C by overcoming the inhibition of the Cdc20
subunit by Emi1. Cyclin B is then polyubiquitinated and targeted
for degradation by the proteasome. CaMKII also promotes the
S287-phosphorylation and inhibition of Cdc25C, thereby inhibiting
reactivation of Cdc2/cyclin B during the after interphase. (B) Phos-
phorylation of S287 on Cdc25C by multiple protein kinases inte-
grates inhibitory signals that delay mitotic initiation.
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phosphorylation is due to the binding of a 14-3-3 protein to
the phosphorylated site, inhibiting its dephosphorylation by
protein phosphatase 2A (Hutchins et al., 2002). The mecha-
nism determining the precise timing of S287 dephosphory-
lation before mitosis therefore remains unclear, but it may
involve inhibition of 14-3-3 binding activity as well as inac-
tivation of CaMKII.
Addition of Ca2 to interphase extracts delays Cdc2/
cyclin B activation, and this inhibition is overcome by
Cdc25C in which the S287 phosphorylation site is abolished,
indicating that S287 phosphorylation by CaMKII is required
for the effect of Ca2. Inhibition of Cdc2/cyclin B activation
and entry into mitosis by CaMKII in egg extracts is consis-
tent with the induction of G2 arrest in cultured mammalian
cells (Planas-Silva and Means, 1992) and in the fission yeast
Schizosaccharomyces pombe (Rasmussen and Rasmussen,
1994) by overexpression of constitutively active forms of
mammalian CaMKII. A similar response is produced by
overexpression in S. pombe of the CaMKII homolog Cmk2,
an oxidative stress response kinase (Alemany et al., 2002;
Sa´nchez-Piris et al., 2002). Inhibition of Cdc25C by CaMKII
may provide a mechanism to restrain entry into mitosis in
vertebrate cells when Ca2 is elevated by extracellular sig-
nals or under stress conditions (Berridge et al., 1998).
Additional Roles for Ca2 and CaMKII during the Cell
Cycle in Xenopus
The observation of oscillations in [Ca2]i and CaMKII activ-
ity in dividing Xenopus embryos (Grandin and Charbon-
neau, 1991; Kubota et al., 1993; Keating et al., 1994) and
cycling egg extracts (Tokmakov et al., 2001; Matsumoto and
Maller, 2002) is consistent with functions for CaMKII during
the early embryonic cell cycles. As well as restraining mitotic
entry at elevated Ca2 concentrations, CaMKII may have
other roles in the control of Cdc2/cyclin B activity. Studies
in Xenopus have previously found that chelation of free Ca2
by Br2BAPTA or addition of a CaMKII-inhibitor peptide
slightly delays entry into mitosis in cycling egg extracts,
suggesting a positive function for Ca2 and CaMKII in
Cdc2/cyclin B activation. Ca2 may be required for cyclin B
synthesis in these extracts, but there also seems to be an
additional role that is independent of protein synthesis
(Lindsay et al., 1995). Consistent with this conclusion, we
found that a CaMKII inhibitor peptide (Figure 8) or
Br2BAPTA (our unpublished data) reduced the level of
Cdc2/cyclin B activity attained after addition of cyclin B90
to a cycloheximide-treated egg extract. In addition to phos-
phorylation of S287, purified CaMKII has been reported to
phosphorylate Cdc25C on multiple sites in vitro, causing a
modest activation of the enzyme (Izumi and Maller, 1995;
Patel et al., 1999). Although these sites are clearly not phos-
phorylated in Xenopus egg extracts during interphase (Izumi
and Maller, 1995), it is possible that CaMKII might also play
a positive role in maintaining Cdc25C activity during mito-
sis when phosphatase activity toward activating phosphor-
ylation sites on Cdc25C is suppressed (Clarke et al., 1993).
CaMKII also plays a role in the inactivation of Cdc2/cyclin
B in prophase extracts that cycle through mitosis, in part,
through inhibition of cyclin B degradation (Lindsay et al.,
1995).
Targeting of S287 by Multiple Kinase Pathways
Although CaMKII is the predominant S287-kinase during
the first postfertilization interphase, other kinases may play
this role at other stages of development. For example, dur-
ing oogenesis, protein kinase A (PKA) is active and has been
recently shown to phosphorylate S287 on Cdc25C (Duck-
worth et al., 2002), keeping Cdc25C inhibited and the oocyte
arrested in G2. The action of the hormone progesterone
inhibits production of cAMP, relieving the inhibitory action
of PKA on Cdc25C and allowing the oocyte to progress
through meiotic maturation. PKA activity oscillates in cy-
cling Xenopus egg extracts and has been shown to inhibit
Cdc2/cyclin B activation (Grieco et al., 1994; Grieco et al.,
1996). It is therefore possible that PKA also contributes to the
control of Cdc25C through phosphorylation of S287 during
embryonic development (Duckworth et al., 2002).
In response to DNA damage or replication arrest, the S287
site of Xenopus Cdc25C is phosphorylated by Chk1 and
Cds1/Chk2 (Kumagai et al., 1998a; Guo and Dunphy, 2000)
in a pathway that is conserved from vertebrates to yeast
(Walworth, 2000). Chk1, Cds1/Chk2, and CaMKII all belong
to the evolutionarily conserved “CaMK” subfamily of pro-
tein Ser/Thr kinases (Hanks and Quinn, 1990; Manning et
al., 2002). This subfamily, which also includes CaMKI, AMP-
activated protein kinase and yeast SNF1, has closely related
catalytic domains but distinct regulatory domains that re-
spond to different cellular stresses. These kinases share the
substrate recognition motif -X--X-X-S/T* (where  is a
hydrophobic and  is a basic residue) (Dale et al., 1995;
Songyang et al., 1996; White et al., 1998; Hutchins et al., 2000;
O’Neill et al., 2002), due to conservation of the residues
lining their catalytic clefts that interact favorably with amino
acid side chains surrounding the target sites in their sub-
strates (Goldberg et al., 1996; Chen et al., 2000). An important
physiological consequence of the shared specificities of these
kinases may be that the cell can integrate diverse signaling
pathways at the same key target. In the case of vertebrate
Cdc25C, the S287/S216 site conforms perfectly to this rec-
ognition motif and may be targeted for phosphorylation by
different kinases in response to cellular stresses as diverse as
DNA damage, DNA replication arrest, and elevated [Ca2]i.
Additionally, extracellular signals that elevate [Ca2]i or
[cAMP]i may cause phosphorylation of this site (Figure 11B).
Chk1, Cds1/Chk2, and possibly other members of this ki-
nase family can also target mammalian Cdc25A and B,
which regulate cyclin-dependent kinase activation in G1 and
G2 (Sanchez et al., 1997; Mailand et al., 2000; Falck et al.,
2001).
Sensitivities of Checkpoint Kinases to Inhibitors
In mammalian cells, UCN-01 overcomes a G2 checkpoint
(Wang et al., 1996; Hirose et al., 2001) and an S-phase check-
point (Feijoo et al., 2001). Because UCN-01 potently inhibits
Chk1, whereas Chk2 is less sensitive (Busby et al., 2000;
Graves et al., 2000), this inhibitor has been used to assign a
role for Chk1 in these checkpoints. However, our studies
have shown that CaMKII is also highly sensitive to UCN-01
(Figure 7B), as are a number of other protein kinases (Davies
et al., 2000). We have also found that DBH, which inhibits
both Chk1 and Cds1/Chk2 and overcomes G2 arrest (Cur-
man et al., 2001), inhibits CaMKII with similar potency.
Although the kinases inhibited by UCN-01 and DBH may
target the same substrates, such as Cdc25 phosphatases,
caution must therefore be exercised when using these com-
pounds to assign roles for particular protein kinases.
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